Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Cancer × cemiplimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 42 Melanoma 19 Neoplasms 14 Neoplasm Metastasis 14 Squamous Cell Carcinoma of Head and Neck 13 Skin Neoplasms 11 Lung Neoplasms 10 Carcinoma, Squamous Cell 8 Carcinoma, Renal Cell 8 Head and Neck Neoplasms 7 Urinary Bladder Neoplasms 6 Recurrence 6 Ovarian Neoplasms 6 Colorectal Neoplasms 5 Carcinoma, Merkel Cell 5 Carcinoma, Basal Cell 5 Breast Neoplasms 5 Triple Negative Breast Neoplasms 4 Prostatic Neoplasms 4 Pancreatic Neoplasms 4 Multiple Myeloma 4 Colonic Neoplasms 4 Adenocarcinoma 4 Mycosis Fungoides 3 Glioblastoma 3 Fallopian Tube Neoplasms 3 Cutaneous Squamous Cell Carcinoma 3 Carcinoma, Hepatocellular 3 Carcinoma 3 Uveal Melanoma 2

Interventions

Nivolumab 14 Surveys and Questionnaires 7 Ipilimumab 6 linrodostat 5 Standard of Care 5 Paclitaxel 5 Bevacizumab 5 temsirolimus 4 Sirolimus 4 Interviews as Topic 4 Gemcitabine 4 Docetaxel 4 relatlimab 3 Vorinostat 3 Pemetrexed 3 Erlotinib Hydrochloride 3 Cetuximab 3 Carboplatin 3 regorafenib 2 apatinib 2 abemaciclib 2 Trastuzumab 2 Sorafenib 2 N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide 2 Magnetic Resonance Spectroscopy 2 Everolimus 2 Dasatinib 2 Cisplatin 2 Chlorogenic Acid 2 Capecitabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02383212 2020-01-27

Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies

Regeneron Pharmaceuticals

Phase 1 Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡